Within the nucleus, PKM2 is a transcriptional coactivator that confers malignant potential to cancer cells through its association with various transcription factors including Oct-4, HIF-1α, β-catenin, and STAT3 [19, 20, 48, 49]. This evidence concerns the gene STAT3 and cancer.